- NEWS AND VIEWS
Calligraphy tool offers clues to the origin of pancreatic cancer
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 621, 265-266 (2023)
doi: https://doi.org/10.1038/d41586-023-02518-4
References
Burdziak, C. et al. Science 380, eadd5327 (2023).
Biankin, A. V. et al. Nature 491, 399–405 (2012).
Ying, H. et al. Genes Dev. 30, 355–385 (2016).
Guerra, C. et al. Cancer Cell 11, 291–302 (2007).
Carriere, C., Young, A. L., Gunn, J. R., Longnecker, D. S. & Korc, M. Biochem. Biophys. Res. Commun. 382, 561–565 (2009).
Hingorani, S. R. et al. Cancer Cell 4, 437–450 (2003).
Maitra, A. et al. Mod. Pathol. 16, 902–912 (2003).
Morris, J. P. IV, Wang, S. C. & Hebrok, M. Nature Rev. Cancer 10, 683–695 (2010).
Ma, Z. et al. Gastroenterology 162, 604–620 (2022).
Schlesinger, Y. et al. Nature Commun. 11, 4516 (2020).
Alonso-Curbelo, D. et al. Nature 590, 642–648 (2021).
Li, Y. et al. Nature Cancer 2, 49–65 (2021).
Carpenter, E. S. et al. Cancer Discov. 13, 1324–1345 (2023).
Collins, M. A. et al. J. Clin. Invest. 122, 639–653 (2012).
Ying, H. et al. Cell 149, 656–670 (2012).
Dey, P. et al. Cancer Discov. 10, 608–625 (2020).
Velez-Delgado, A. et al. Cell Mol. Gastroenterol. Hepatol. 13, 1673–1699 (2022).
Helms, E. J. et al. Cancer Discov. 12, 484–501 (2022).
Elyada, E. et al. Cancer Discov. 9, 1102–1123 (2019).
Competing Interests
The authors declare no competing interests.
Vaccine boosts T cells that target pancreatic tumours
A metabolic vulnerability of pancreatic cancer
